abstract |
Use of 5-substituted-2, 4-thiazolidinediones of formula (I) or pharmaceutically acceptable salts thereof in preparation of the medicaments for modulating insulin-like growth factor 1 receptor (IGFlR). The compounds of the present invention can inhibit the activity of IGFlR kinase and can be used to treat cancer. |